LEXENT BIO
Lexent Bio is building novel liquid biopsy technology to change the way we diagnose and treat cancer.
LEXENT BIO
Industry:
Biotechnology Health Care Wellness
Founded:
2016-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.lexentbio.com
Total Employee:
11+
Status:
Closed
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
SPF Amazon IPv6 Microsoft Azure DNS Amazon Ohio Region NSONE
Current Employees Featured
Founder
Investors List
Charge Ventures
Charge Ventures investment in Venture Round - Lexent Bio
iFly.vc
iFly.vc investment in Seed Round - Lexent Bio
Official Site Inspections
http://www.lexentbio.com
- Host name: ec2-98-83-184-133.compute-1.amazonaws.com
- IP address: 98.83.184.133
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Lexent Bio"
Lexent Bio - Crunchbase Company Profile & Funding
Where is Lexent Bio 's headquarters? Lexent Bio is located in San Francisco, California, United States. Who invested in Lexent Bio? Lexent Bio has 2 investors including Charge Ventures …See details»
Foundation Medicine Acquires Lexent Bio, Inc., to Accelerate …
Jun 13, 2020 “Lexent Bio's platforms align well with our liquid biopsy research and development strategy, which ultimately aims to bring the latest research innovations into routine clinical use …See details»
Lexent Bio Company Profile 2024: Valuation, Investors …
Lexent Bio is headquartered in San Francisco, CA. What industry is Lexent Bio in? Lexent Bio’s primary industry is Decision/Risk Analysis. Is Lexent Bio a private or public company? Lexent Bio is a Private company. What is the current …See details»
Lexent Bio - Products, Competitors, Financials, Employees, …
Lexent Bio is building novel liquid biopsy technology to change the way cancer is managed. Use the CB Insights Platform to explore Lexent Bio's full profile. ... "I am excited to join this very …See details»
Foundation Medicine acquires Lexent Bio - 2020-06-12 - Crunchbase
Jun 12, 2020 Lexent Bio Lexent Bio is building novel liquid biopsy technology to change the way we diagnose and treat cancer. Acquiring Organization: Foundation Medicine Foundation …See details»
Foundation Medicine acquires liquid biopsy developer Lexent Bio
Jun 15, 2020 Foundation Medicine has picked up liquid biopsy company Lexent Bio in an acquisition aimed at expanding the Roche subsidiary’s multi-omics platforms in cancer …See details»
Foundation Medicine Eyes Liquid Biopsy Expansion, DNA …
Jun 12, 2020 Foundation Medicine, a member of the Roche Group, said today it has completed the acquisition of precision oncology company Lexent Bio for an undisclosed price, in a deal …See details»
Foundation Medicine Acquires Lexent Bio, Inc., to …
Lexent Bio’s novel monitoring platform is currently in development and is based on low-pass whole genome sequencing (WGS) and DNA methylation analysis. Foundation Medicine plans to further incorporate WGS and methylation into …See details»
Roche's Foundation Medicine acquires precision cancer company …
Jun 15, 2020 Foundation Medicine Inc., a unit of Roche Holding AG, completed the acquisition of precision oncology company Lexent Bio Inc. The acquisition expands Foundation …See details»
Lexent Bio - LinkedIn
Lexent Bio Biotechnology Research San Francisco, California 1,274 followers Better cancer treatment decisions, fasterSee details»
Foundation Medicine Acquires Lexent Bio, Inc., to Accelerate …
Jun 12, 2020 Acquisition will expand Foundation Medicine’s multiomics capabilities, including the adoption of DNA methylation to evaluate cancer progression in broader patient populations …See details»
Wilson Sonsini Advises Lexent Bio in Acquisition by Foundation …
Jun 15, 2020 On June 12, Foundation Medicine (member of the Roche Group), a Massachusetts-based molecular information company providing genomic profiling services …See details»
Foundation Medicine Acquires Lexent Bio, Inc., to Accelerate …
Jun 12, 2020 Lexent Bio's novel monitoring platform is currently in development and is based on low-pass whole genome sequencing (WGS) and DNA methylation analysis. Foundation …See details»
Lexent Bio Locations - Contract Research Map
Lexent Bio 10355 Science Center Drive Suite 150 San Diego, CA, 92121 United States Lexent Bio is building novel liquid biopsy technology to change the way we manage cancer. Our liquid …See details»
Foundation Medicine Acquires Precision Oncology Company …
Jun 12, 2020 Foundation Medicine, Inc., announced that it has completed the acquisition of Lexent Bio, Inc., a precision oncology company located in California, developing novel …See details»
Lexent Bio - Craft
Lexent Bio has 5 employees at their 1 location. See insights on Lexent Bio including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Lexent, Illumina Enter Partnership for Cancer Monitoring Liquid …
Nov 11, 2019 Precision oncology company Lexent Bio, which is developing liquid biopsy systems for the monitoring of cancer has announced a partnership with Illumina to develop an …See details»
Foundation Medicine Acquires Lexent Bio, Inc., to Accelerate
Jun 12, 2020 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Foundation Medicine, Inc., today announced that it has completed the acquisition of Lexent Bio, Inc., a precision oncology …See details»
Foundation Medicine Shifts Focus to Early Cancer Detection With …
Jun 30, 2020 Foundation Medicine, a Roche subsidiary, took a step in that direction with its acquisition of Lexent Bio earlier this month, a decision that stemmed from "a desire to have …See details»
Foundation Medicine Acquires Lexent Bio to Expand Liquid Biopsy ...
Jun 12, 2020 Lexent Bio's monitoring platform is currently in development and based on low-pass whole-genome sequencing and DNA methylation analysis, which Foundation said in a …See details»